Clinical focus and interest:
Professor Peters’ current research projects focus on innovative multimodal Stage III non–small cell lung cancer (NSCLC) treatment strategies and targeted therapies for NSCLC, as well as immunotherapy combinations and new immunomodulatory treatments across thoracic malignancies.
Professor Peters received both her doctorate in medicine and her PhD from Lausanne University Hospital. After completing her clinical education in medical oncology and molecular biology in Switzerland and Italy, she specialized in thoracic tumors, lung cancer, and pleural tumors. She has authored more than 300 peer-reviewed manuscripts and book chapters. She also acts as the local principal investigator (PI) for lung trials opened at the Lausanne branch of Ludwig Cancer Research focused on Phase I predictive biomarkers and immunotherapy for thoracic malignancies, and is a co-PI of several other trials.
Professor Peters served for several years as the deputy editor of the Journal of Thoracic Oncology, and she currently serves on the editorial board of Annals of Oncology. She is active in the educational programs of the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer. Professor Peters is the current editor of the ESMO lung cancer clinical practice guidelines and served as the chair of the ESMO Women for Oncology Committee.